Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum TAAT Global Alternatives Inc C.TAAT

Alternate Symbol(s):  TOBAF

TAAT Global Alternatives Inc. is a vertically integrated consumer product and distribution company. The Company develops, manufactures, and distributes alternative product categories, such as tobacco and reduced-risk alternatives, hemp, kratom, and other emerging consumer packaged goods (CPG) segments. The Company operates through two segments: the sale of non-tobacco and tobacco products. The... see more

CSE:TAAT - Post Discussion

TAAT Global Alternatives Inc > A current state of affairs for big tobacco
View:
Post by synectix on Aug 05, 2022 7:20am

A current state of affairs for big tobacco

Tobacco stocks are a longtime favorite of dividend investors, and sister companies Altria Group(NYSE: MO) and Philip Morris International(NYSE: PM) dominate the industry.

Since Altria spun off Philip Morris more than a decade ago, the two companies have taken different approaches to ready their companies for a future where cigarettes aren't their main revenue source. Both companies have their advantages, but one is likely to outperform the other. Here is how these two dividend stalwarts stack up.

Both companies put cash in your pockets

Altria sells tobacco and nicotine products in the United States, headlined by the Marlboro brand of cigarettes. Philip Morris also sells Marlboro, but exclusively in non-U.S. markets. Marlboro is the leading cigarette brand in America, and while it has more competition internationally, it contributed 37% of Philip Morris' shipment volumes in 2020.

Warren Buffett (who doesn't own or advocate owning either stock) once described cigarettes as something that cost a penny to make, sell for a dollar, and are addictive. In other words, Altria and Philip Morris enjoy substantial profit margins, routinely getting $0.39 and $0.35, respectively, of free cash flow from each revenue dollar.

The addictive nature of nicotine has made tobacco companies resilient through up and down markets and economies. Altria is a Dividend King with 52 consecutive dividend raises. Meanwhile, Philip Morris has raised its payout yearly as a public company.

You can see how each dividend compares in the chart below:

MO Dividend Yield Chart

MO Dividend Yield data by YCharts

Altria's 8.2% dividend yield is excellent, but Philip Morris isn't slouching either. You can do great with Altria for income, but the dividend payout ratio for Philip Morris is notably lower, which leaves more room for the payout's long-term growth.

Going beyond smoking

The public has known that cigarettes are a health hazard since the Surgeon General's first public warning in 1964 (and many knew it even before then). The dividends have flowed for decades despite this, but the smoking rate is steadily decreasing, and tobacco companies ship fewer cigarettes each year.

There is a common goal for Altria and Philip Morris to build a sustainable business beyond cigarettes, but they've taken two different paths to get there. Philip Morris has spent nearly the past decade growing its IQOS brand, a heat-not-burn tobacco device that produces inhalable vapor with fewer toxins than regular cigarette smoke. IQOS now contributes 30% of the company's total revenue.

Altria's tried buying assets to diversify beyond smokeable products but hasn't had much luck. It has majority ownership of on! nicotine pouches, which have steadily grown in recent years. Altria's 2018 $12.8 billion investment into electronic cigarette maker Juul has already become one of the biggest mistakes in corporate history. A recent Food and Drug Administration (FDA) ruling has prohibited the sale of Juul in the States, which all but makes Altria's investment worthless.

Altria and Philip Morris still rely heavily on smokeable products, and they have a long way to go before they can financially stand on their own without tobacco sales. Still, Altria seemingly has more questions about its long-term future than Philip Morris at the moment.

Looking at valuation

Wall Street has placed very different valuations on Altria and Philip Morris for as similar as they are. Philip Morris has a forward price-to-earnings ratio (P/E) of almost 17.6, while Altria's is just 9.1, nearly 50% lower. Naturally, investors want to know if this is justified. It's a tricky question to answer; the companies have similar growth expectations. Analysts believe the companies will grow earnings per share (EPS) by annual averages of 4% (Altria) and 4.5% (Philip Morris) over the next three to five years.

Altria is in Wall Street's dog house for its mistakes in the Juul acquisition. Understandably, spending $12.8 billion on something and declaring it nearly worthless less than four years later is not ideal. But the stock's been punished and then some; meanwhile, Altria's legacy business continues carrying water for shareholders.

Which stock is worth further consideration?

If you're looking for the total package, where both dividends and share price are important to you, Philip Morris International has a slight edge. The company's IQOS brand was built within Philip Morris and has enormous potential.

Altria's colossal dividend and dirt cheap valuation could mean it is the better stock in the short term. But there are a lot of questions about how long Altria's cigarette business can drive growth and where future long-term revenue will come from. This investor would rather own Philip Morris for that reason.

Comment by IIIIIIIIIIIIIIl on Aug 05, 2022 7:37am
Great read but TAAT is not tobacky for sure.I just got a email blast to run and hide from buying TAAT shares
Comment by Frogzilla on Aug 05, 2022 7:46am
This post has been removed in accordance with Community Policy
Comment by synectix on Aug 05, 2022 8:30am
Whatever your position....pump or dump.....The article is intended to highlight the repositioning going on within the tobacco industry.....my belief is that TAAT(when and with patents in hand) will become an attractive takeover target(although not at the hyped up JUUL level evaluations TAAT investors dreamed of back in the early days of TAAT's first runup)......Altria will be in the "Once ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities